July 18, 2022
It’s no secret that the healthcare industry is experiencing a high turnover rate among pharmacists. Preliminary data from the Canadian Pharmacy Mental Health and Workforce Wellness […]
April 18, 2022
We have finally started to receive encouraging news about the COVID-19 pandemic, there are several viable vaccine candidates that have entered their final phases of clinical trials and are likely to be available in the next 6 months.
March 21, 2022
We have finally started to receive encouraging news about the COVID-19 pandemic, there are several viable vaccine candidates that have entered their final phases of clinical trials and are likely to be available in the next 6 months.
September 10, 2021
We have finally started to receive encouraging news about the COVID-19 pandemic, there are several viable vaccine candidates that have entered their final phases of clinical trials and are likely to be available in the next 6 months.
August 11, 2021
We have finally started to receive encouraging news about the COVID-19 pandemic, there are several viable vaccine candidates that have entered their final phases of clinical trials and are likely to be available in the next 6 months.
June 15, 2021
We have finally started to receive encouraging news about the COVID-19 pandemic, there are several viable vaccine candidates that have entered their final phases of clinical trials and are likely to be available in the next 6 months.
June 8, 2021
We have finally started to receive encouraging news about the COVID-19 pandemic, there are several viable vaccine candidates that have entered their final phases of clinical trials and are likely to be available in the next 6 months.
April 21, 2021
We have finally started to receive encouraging news about the COVID-19 pandemic, there are several viable vaccine candidates that have entered their final phases of clinical trials and are likely to be available in the next 6 months.
April 1, 2021
We have finally started to receive encouraging news about the COVID-19 pandemic, there are several viable vaccine candidates that have entered their final phases of clinical trials and are likely to be available in the next 6 months.
